Hybrid fiber for promoting tissue regeneration, preparation method thereof, and fiber structure using the same
By mixing and twisting the functional regenerated silk protein fibers with polymer fibers, hybrid fibers with excellent mechanical properties and good biocompatibility, the problem of insufficient strength and cell compatibility of existing materials is solved, and the problem of inadequate cellular compatibility is achieved. Widely used in the field of bioremediation.
Patent Information
- Application Number
- CN202210425644.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-04-21
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2042-04-21
AI Technical Summary
The existing tissue-promoting regeneration materials have shortcomings in strength and regulatory performance, which cannot meet high-strength needs, and the cellular compatibility of traditional materials is poor, which limits their application in the field of bioremediation.
The functional regenerated silk protein fibers and polymer fibers are mixed and twisted to form a new multi-stage hybrid fiber material. By preparing high-concentration regenerated silk protein stock solution, spinning the regenerated silk protein fibers containing growth factors, and the surface of the polymer fiber is carried out. Plasma treatment and silk protein modification form hybrid fibers with excellent mechanical properties and good biocompatibility.
It achieves high strength and good cell compatibility of fiber materials, can quickly induce tissue cell adhesion and differentiation, and is suitable for different use scenarios such as artificial ligaments, hernia patches, tendons, etc., and broadens the application scope of the material.
Smart Images

Figure CN115679695B_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of preparation of fiber hybrid materials, and relates to a hybrid fiber for promoting tissue regeneration, a preparation method thereof, and a fiber structure using the fiber. Background Art
[0002] The method of combining engineered biomaterials to regenerate body tissues is called in situ tissue regeneration. In situ tissue regeneration uses the body's regenerative potential to control cell function for tissue repair. The design of biomaterials for in situ tissue engineering requires precise control of biophysical and biochemical cues to guide endogenous cells to the site of injury. These cues are needed to induce regeneration by regulating the extracellular microenvironment or driving cell reprogramming. Therefore, the research on materials that promote tissue regeneration has aroused widespread interest among researchers and has developed rapidly. Such materials can generally induce the repair and growth of surrounding tissue cells and have very important applications in the biomedical field. For example, PGA (polyglycolic acid) in traumatic bone materials can promote bone healing; bioactive glass dressings contained in medical dressings can activate the expression of genes related to wound healing, promote the proliferation and differentiation of fibroblasts, and promote tissue repair and regeneration; GTR (guided tissue regeneration) membranes commonly used in periodontal surgery can guide bone-derived cells to preferentially occupy the repair area to repair the defect area. For such materials that promote tissue regeneration, they should have good biocompatibility and biodegradability to minimize damage to the human body during use. However, most materials that can promote tissue regeneration often have some shortcomings, such as insufficient strength, which makes them incapable of being used in scenarios with higher strength requirements; they can only promote the regrowth of certain tissue cells, and their controllable performance is insufficient.
[0003] These deficiencies can be addressed by combining materials that promote tissue regeneration with traditional materials to adjust the material properties.
[0004] Silk protein (protein removed from natural silk without sericin, also known as fibroin) is a natural high molecular weight fibrous protein extracted from silk. It has excellent biocompatibility and good physical and chemical properties. It can be slowly degraded into amino acids in the body, and the degradation products are harmless to organisms. Studies have shown that silk protein materials have more unique mechanical properties than other natural fibers and high-performance synthetic fibers. They can be processed by different methods to obtain a variety of forms and change surface properties. However, since the mechanical properties of regenerated silk protein cannot fully meet the requirements of some human environments, it can often only be applied to some low-intensity biological repair fields.
[0005] The shortcomings of the tissue growth promoting material itself limit the application range of the material to a great extent. To solve this problem, the tissue regeneration promoting material can be combined with traditional materials, and a new composite material can be prepared through a specific process, which can give the material a certain strength and function while retaining the excellent biocompatibility and repair performance of the material, thereby widening the application range of the material. For example, the material PET (polyethylene terephthalate) of artificial ligament has a therapeutic effect similar to that of autologous grafts, or even better than that of autologous grafts, but the cell compatibility of PET ligament is poor, which is not conducive to cell adhesion, proliferation and bone differentiation on its surface. Regenerated silk fibroin can be made into fibrous material through spinning process, and regenerated silk fibroin can be mixed with PET to prepare artificial ligament, and growth factors are added to the regenerated silk fibroin to improve the biocompatibility of ligament and promote the proliferation and differentiation of bone marrow cells.
[0006] Although the existing patent also mentions the use of silk protein to modify artificial ligaments (authorization announcement number CN203841854U), the method in the patent only soaks the PET ligament in the silk protein solution for a period of time without treating the PET fiber, so the silk protein coating is easy to fall off and the force is not strong. There is also a patent that mentions the use of regenerated silk protein to coat medical patches (publication number CN 101195043A), which improves the biocompatibility of medical patches and reduces the adhesion between body tissues during use, but fails to further promote the growth and repair of tissue cells. Therefore, a method for preparing a regenerated silk protein polymer material that is more reliable and has better tissue repair function is needed. Summary of the invention
[0007] In view of the defects of the prior art, the purpose of the present invention is to provide a hybrid fiber material capable of promoting tissue regeneration and a preparation method thereof. On the basis of medical polymer materials such as PET / PP / etc. that can be used for biological repair, functional regenerated silk protein fibers are mixed and twisted with polymer fibers to form a new multi-level hybrid fiber material.
[0008] The method for preparing hybrid fibers capable of promoting tissue regeneration proposed by the present invention comprises the following steps:
[0009] S1: preparing high concentration regenerated silk protein stock solution;
[0010] S2: preparing a regenerated silk protein spinning solution containing growth factors that promote tissue regeneration, wherein the growth factors are ions, compounds or mixtures that can promote tissue growth;
[0011] S3: Spinning regenerated silk protein fibers containing growth factors using the regenerated silk protein spinning solution prepared in step S2;
[0012] S4: Plasma treatment of the polymer fiber surface;
[0013] S5: coating the surface of the polymer fiber treated with the plasma in step S4 with a silk protein solution;
[0014] S6: Twisting the regenerated silk protein fiber containing growth factors obtained in step S3 and the surface-modified polymer fiber obtained in step S5 in an appropriate ratio to prepare hybrid fibers.
[0015] Preferably, the growth factors include but are not limited to magnesium ion compounds, calcium ions, FGF21 or nano zinc.
[0016] Preferably, the spinning method in step S3 includes wet spinning, dry spinning or electrospinning.
[0017] Preferably, the polymer fiber is a medical polymer fiber material that can be used for biological repair, including but not limited to PET fiber, PP fiber, PCL fiber and mixed fibers of the above fibers.
[0018] Furthermore, the method for preparing high-concentration regenerated silk protein stock solution in step S1 is as follows: a) degumming: putting mulberry silk into an aqueous solution of sodium carbonate, sodium bicarbonate or a mixed solution of sodium carbonate and sodium bicarbonate, heating and boiling, taking out and washing with purified water, removing sericin, leaving silk protein, drying the silk protein, obtaining dried silk protein for standby use; b) dissolving: dissolving the dried silk protein in an aqueous solution of lithium bromide to obtain a mixed solution containing silk protein and a small amount of insoluble particles; c) filtering: filtering the mixed solution multiple times to obtain a clarified lithium bromide protein solution; d) ultrafiltration: taking the clarified solution, adding purified water to dilute it, passing it into an ultrafiltration system for desalination, and concentrating the silk protein concentration of the final solution to 5-40wt%.
[0019] Furthermore, the method for preparing the regenerated silk protein spinning solution containing growth factors in step S2 is: stirring and dispersing the growth factors in deionized water to obtain a dispersion, slowly adding the dispersion to the high-concentration regenerated silk protein aqueous solution obtained in step S1, and fully mixing to obtain a high-concentration regenerated silk protein spinning solution containing growth factors, and by controlling the concentration of the dispersion, the concentration of the regenerated silk protein aqueous solution and the mixing ratio of the two, the concentration of silk protein in the final spinning solution containing growth factors is controlled to be 5-40wt%.
[0020] Furthermore, the method for preparing the regenerated silk protein fibers containing growth factors in step S3 is: using the regenerated silk protein spinning solution containing growth factors prepared in step S2 to spin the regenerated silk protein fibers containing growth factors using a spinning device.
[0021] Furthermore, the method for plasma treatment of the polymer fiber surface in step S4 is: placing the polymer fiber in an atmospheric low-temperature plasma discharge experimental device, using a gas-solid reactor as a container, helium as a carrier gas, a voltage of 30-50V, a current intensity of 1-3A, and a plasma treatment time of 10-200 seconds.
[0022] Furthermore, the method of using the silk protein solution in step S5 to coat the surface of the polymer fiber in step S4 is: adding growth factors to the silk protein solution, stirring to dissolve, and immersing the polymer fiber after plasma treatment in step S4 in the above-mentioned silk protein solution with added growth factors.
[0023] Furthermore, in step S6, the ratio of the regenerated silk protein fibers containing growth factors to the surface-treated polymer fibers is 1:99 to 99:1, preferably 1:50 to 50:1, more preferably 1:20 to 20:1, and most preferably 1:4 to 4:1.
[0024] The present invention also proposes a fiber structure, which is obtained by subjecting the above-mentioned hybrid fibers to corresponding process treatments to obtain structures suitable for different usage scenarios, including but not limited to artificial ligaments, artificial hernia patches, artificial tendons and slings.
[0025] Beneficial effects of the present invention:
[0026] The present invention spins high-concentration liquid crystal silk protein into high-performance fibers through a unique green molding process. This is a protein denaturation process in which the silk protein changes from a random coil / α-helix conformation to a β-folded conformation. The special protein structure of silk protein increases the complexity of molding. Based on the molding mechanism of silk fibers, the present invention combines exquisite and complex spinning technology to control molecular orientation and obtain natural silk fibers with excellent comprehensive mechanical properties.
[0027] In addition, the present invention increases the surface roughness of the polymer fiber by plasma treatment, thereby enhancing cell adhesion and facilitating the modification of silk protein on the fiber surface; after being mixed and woven with regenerated silk protein spinning fibers containing growth factors, it can quickly induce tissue cell adhesion and cell differentiation in the early stage of implantation into the human body, and can also play a role in slow repair during the subsequent growth process. BRIEF DESCRIPTION OF THE DRAWINGS
[0028] Figure 1 A flow chart of a method for preparing a hybrid fiber material for promoting tissue regeneration;
[0029] Figure 2Schematic diagram of the spinning process in step S3, the meanings of the reference numerals in the figure are: A: nitrogen gas cylinder; B: pressure regulator; C: spinning solution storage cylinder; D: spinning solution; E: extrusion port; F: coagulation bath; G: traction roller; H: take-up roller;
[0030] Figure 3 The cell growth condition on the artificial ligament prepared in Example 1;
[0031] Figure 4 Schematic diagram of the expression of type 1 collagen mRNA after cells were seeded on the artificial ligament prepared in Example 1;
[0032] Figure 5 Schematic diagram of the expression of osteocalcin mRNA after cells were seeded on the artificial ligament prepared in Example 1;
[0033] Figure 6 is a schematic diagram of the expression of osteopontin mRNA after cells were seeded on the artificial ligament prepared in Example 1;
[0034] Figure 7 This is a test diagram of the mechanical properties of the artificial ligament prepared in Example 1;
[0035] Figure 8 This is a surface morphology of the silk protein hybrid fiber prepared in Example 1;
[0036] Fig. 9 This is a real picture of the artificial hybrid woven ligament prepared in Example 1. DETAILED DESCRIPTION
[0037] The present invention will be further described below in conjunction with specific embodiments. It should be understood that the embodiments are only used to illustrate the present invention and are not intended to limit the scope of protection of the present invention. In addition, it should be understood that after reading the contents disclosed in the present invention, those skilled in the art may make various changes or modifications to the present invention, and these equivalent forms also fall within the scope of protection defined by the present invention.
[0038] Example 1
[0039] This embodiment provides a method for preparing an artificial ligament capable of promoting the growth of bone marrow cells, comprising the following steps:
[0040] S1: preparing a high concentration regenerated silk protein stock solution, specifically: a) degumming: putting the silk of mulberry silk into a boiling aqueous solution of sodium carbonate, sodium bicarbonate or a mixed solution of sodium carbonate and sodium bicarbonate with a mass fraction of 0.1-5%, heating and boiling for 10-120 minutes, taking out and washing with purified water, removing the sericin, leaving the silk protein, drying the silk protein at 25-100°C, obtaining the dried silk protein, and setting aside; b) dissolving: dissolving the dried silk protein in a 9.3M lithium bromide (LiBr) aqueous solution at a mass volume ratio of less than or equal to 1:1 , heat in a water bath at 25-100°C for 10-120 minutes until the silk protein is fully dissolved to obtain a mixed solution containing silk protein and a small amount of insoluble particles; c) filtration: the mixed solution is first filtered out with a 50-200 mesh filter bag to remove insoluble particle impurities, and then filtered with glass fiber filter paper and PES filter paper in turn to obtain a clarified lithium bromide protein solution; d) ultrafiltration: the clarified solution is diluted with one times of pure water, and then passed into an ultrafiltration system for desalination, the membrane has a molecular weight cutoff of 10-200kda, and the silk protein concentration of the final solution is concentrated to 5-40wt%.
[0041] S2: preparing a regenerated silk protein spinning solution containing growth factors. In this embodiment, magnesium ions are used as growth factors. The specific method is as follows: stirring and dispersing magnesium chloride in deionized water for 1-24 hours to obtain a magnesium chloride solution with a mass fraction of 1-10wt%. This solution is slowly added to the high-concentration regenerated silk protein aqueous solution obtained in step S1 to obtain a spinning solution containing magnesium chloride, and the concentration of silk protein in the final spinning solution containing magnesium chloride is controlled to be 5-40wt%, wherein magnesium chloride accounts for 0.1-10% of the mass percentage of the solid content in the solution, and after fully mixing, a high-concentration regenerated silk protein and magnesium chloride mixed solution is obtained.
[0042] S3: Using a wet spinning method to produce regenerated silk protein fibers containing growth factors: using the high-concentration regenerated silk protein spinning solution containing growth factors prepared in step S2, using an ammonium sulfate aqueous solution with a solid content of 1-50wt% as a coagulation bath, using a Figure 2 The spinning device shown spins highly stretched regenerated silk protein fibers containing growth factors. The stretching ratio of the regenerated silk protein fibers is 2-8 times, the diameter of the spinneret used for wet spinning is 50-300 μm, and the coagulation bath temperature is 25-80° C. All newly spun regenerated silk protein fibers are placed in an ammonium sulfate aqueous solution with a solid content of 1-50wt% and further cured at room temperature for 1-10 hours, and then soaked in deionized water to remove the ammonium sulfate on the regenerated silk protein fibers. Finally, the regenerated silk protein fibers are taken out, washed with deionized water, and dried naturally.
[0043] S4: PET fiber surface plasma treatment: The PET fiber is placed in an atmospheric low-temperature plasma discharge experimental device for plasma treatment. A gas-solid reactor is used as a container, helium is used as a carrier gas, the voltage is selected to be 30-50v, and the current intensity is 1-3A. The plasma treatment time is 10-200 seconds.
[0044] S5: Silk protein solution coating modification: Add 2.0 wt% magnesium chloride to a 10 wt% silk protein solution, stir to dissolve, and soak the PET fiber treated with plasma in step S4 in the silk protein solution with magnesium chloride added for 24 hours to obtain a silk protein modified film with growth factors on the surface of the PET fiber.
[0045] S6: Twisting the regenerated silk protein fiber containing growth factors obtained in step S3 and the surface-treated polymer fiber obtained in step S5 at a ratio of 1:4 to form fibers. The surface morphology of the obtained silk protein hybrid fiber is as follows: Figure 8 shown.
[0046] S7: Weaving of artificial ligament: The hybrid fibers obtained in S6 are weaved to obtain artificial ligaments of suitable size, such as Fig. 9 shown.
[0047] Figure 3 The figure shows the growth of cells on the artificial ligament prepared by the method of Example 1. In order to study the cell compatibility of the artificial ligament, mouse embryonic osteoblast precursor cells (MC3T3-E1) were inoculated on the artificial ligament, and the calcein-AM method was used to evaluate the growth of cells on the ligament. Figure 3 It can be seen that as the culture time increases, the number of cells on the ligament gradually increases, indicating that the artificial ligament prepared by the method of the present invention has good cell compatibility.
[0048] In addition, the effects of artificial ligaments on the osteogenic differentiation of MC3T3-E1 cells were evaluated by real-time quantitative polymerase chain reaction (RT-qPCR) analysis of type 1 collagen (COL1), osteocalcin (OCN), and osteopontin (OPN). Figure 4 , Figure 5 and Figure 6 It can be seen that after 14 and 21 days of cell culture, the expression levels of type 1 collagen mRNA, osteocalcin mRNA and osteopontin mRNA increased significantly, which means that the material of the artificial ligament has a significant effect of inducing tissue growth.
[0049] Figure 7 The figure shows the mechanical properties of the artificial ligament. It can be seen from the figure that the maximum load in the tensile test of the artificial ligament is 153.9N, which reflects good mechanical properties.
[0050] Example 2
[0051] This embodiment provides a method for preparing a hernia patch capable of promoting tissue growth, comprising the following steps:
[0052] S1: preparing a high-concentration regenerated silk protein stock solution, the method is the same as step S1 of Example 1.
[0053] S2: Prepare a regenerated silk protein spinning solution containing growth factors. In this embodiment, FGF21 is used as a growth factor. The specific method is: stir and disperse FGF21 in deionized water for 1-24 hours to obtain a FGF21 solution with a mass fraction of 1-10wt%. This solution is slowly added to the high-concentration regenerated silk protein aqueous solution obtained in step S1 to obtain a spinning solution containing FGF21, and the concentration of silk protein in the final spinning solution containing FGF21 is controlled to be 5-40wt%, wherein FGF21 accounts for 0.1-10% of the mass percentage of the solid content in the solution, and after fully mixing, a high-concentration regenerated silk protein and FGF21 mixed solution is obtained.
[0054] S3: Prepare regenerated silk protein fibers containing growth factors by dry spinning method: Use the high-concentration regenerated silk protein spinning solution containing growth factors prepared in step S2, use high-temperature air as a coagulation bath, and use a spinning device to spin highly stretched regenerated silk protein fibers containing growth factors. The stretching ratio of the regenerated silk protein fiber is 2-8 times, the spinneret diameter of the spinneret used for dry spinning is 50-300 μm, and the coagulation bath temperature is 25-80°C. All newly spun raw silk protein fibers are placed in an ethanol aqueous solution and further cured at room temperature for 1-10 hours. Finally, the regenerated silk protein fibers are taken out, washed with deionized water, and dried naturally.
[0055] S4: PP (polypropylene) fiber surface plasma treatment: PP fiber is placed in an atmospheric low-temperature plasma discharge experimental device for plasma treatment. A gas-solid reactor is used as a container, helium is used as a carrier gas, the voltage is selected to be 30-50v, and the current intensity is 1-3A. The plasma treatment time is 10-200 seconds.
[0056] S5: Silk protein solution coating modification: Add 0.1wt% FGF21 to a 10wt% silk protein solution, stir to dissolve, and soak the PP fiber treated with plasma in step S4 in the silk protein solution with added FGF21 for 24 hours to obtain a layer of silk protein modified film with growth factors on the surface of the PP fiber.
[0057] S6: twisting the regenerated silk protein fiber containing growth factors obtained in step S3 and the surface-treated polymer fiber obtained in step S5 into fibers in a ratio of 1:4.
[0058] S7: Weaving of hernia patch: Weaving the hybrid fibers obtained in step S6 to obtain an artificial hernia patch of appropriate size.
[0059] Example 3
[0060] This embodiment provides a method for preparing an artificial tendon capable of promoting tissue growth, comprising the following steps:
[0061] S1: preparing a high-concentration regenerated silk protein stock solution, the method is the same as step S1 of Example 1.
[0062] S2: preparing a regenerated silk protein spinning solution containing growth factors. In this embodiment, nano zinc is used as the growth factor. The specific method is as follows: stirring and dispersing nano zinc in deionized water for 1-24 hours to obtain a nano zinc dispersion. This solution is slowly added to the high-concentration regenerated silk protein aqueous solution obtained in step S1 to obtain a spinning solution containing nano zinc, and the concentration of silk protein in the final spinning solution containing nano zinc is controlled to be 5-40wt%, wherein nano zinc accounts for 0.1-10% of the mass percentage of the solid content in the solution, and after fully mixing, a high-concentration regenerated silk protein and nano zinc mixed solution is obtained.
[0063] S3: Preparation of regenerated silk protein fibers containing growth factors by electrospinning: Using the high-concentration regenerated silk protein spinning solution containing growth factors prepared in step S2, regenerated silk protein fibers containing growth factors are spun by electrospinning equipment. The electrospinning process is carried out at room temperature and the relative humidity is 50%. All newly spun raw silk protein fibers are placed in an ethanol aqueous solution and further cured at room temperature for 1-10 hours. Finally, the regenerated silk protein fibers are taken out, washed with deionized water, and dried naturally.
[0064] S4: PCL (polycaprolactone) fiber surface plasma treatment: PCL fiber is placed in an atmospheric low-temperature plasma discharge experimental device for plasma treatment. A gas-solid reactor is used as a container, helium is used as a carrier gas, the voltage is selected to be 30-50v, and the current intensity is 1-3A. The plasma treatment time is 10-200 seconds.
[0065] S5: Silk protein solution coating modification: add 0.5wt% nano zinc to the 10wt% silk protein solution, stir to dissolve, and soak the PCL fiber treated by plasma in step S4 in the silk protein solution containing nano zinc for 24 hours to obtain a layer of silk protein modified film with growth factors on the surface of the PCL fiber.
[0066] S6: twisting the functional regenerated silk protein fiber obtained in step S3 and the surface-treated polymer fiber obtained in step S5 into fibers in a ratio of 1:4.
[0067] S7: Weaving of artificial tendon: Weaving the hybrid fibers obtained in step S6 to obtain an artificial tendon of a suitable size.
[0068] The above is an explanation of the embodiments of the present invention. However, the present invention is not limited to the above embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for preparing hybrid fibers capable of promoting tissue regeneration, characterized in that: It consists of the following steps: S1: preparing high concentration regenerated silk protein stock solution; S2: preparing a regenerated silk protein spinning solution containing growth factors that promote tissue regeneration, wherein the growth factors are ions, compounds or mixtures that can promote tissue growth; the method for preparing the regenerated silk protein spinning solution containing growth factors in step S2 is: stirring and dispersing the growth factors in deionized water to obtain a dispersion, slowly adding the dispersion to the high-concentration regenerated silk protein aqueous solution obtained in step S1, and mixing them thoroughly to obtain a high-concentration regenerated silk protein spinning solution containing growth factors, and controlling the concentration of the dispersion, the concentration of the regenerated silk protein aqueous solution and the mixing ratio of the two to control the concentration of the silk protein in the spinning solution containing the growth factors to be 5-40wt%; S3: using the regenerated silk protein spinning solution prepared in step S2 to spin regenerated silk protein fibers containing growth factors; the method for preparing regenerated silk protein fibers containing growth factors in step S3 is: using the regenerated silk protein spinning solution containing growth factors prepared in step S2, using a spinning device to spin regenerated silk protein fibers containing growth factors; the spinning method in step S3 includes wet spinning or electrospinning; S4: Plasma treatment is performed on the surface of the polymer fiber; the method for plasma treatment on the surface of the polymer fiber in step S4 is: placing the polymer fiber in an atmospheric low-temperature plasma discharge experimental device, using a gas-solid reactor as a container, helium as a carrier gas, selecting a voltage of 30-50V, a current intensity of 1-3A, and a plasma treatment time of 10-200 seconds; the polymer fiber is a medical polymer fiber material that can be used for biological repair, including PET fiber, PP fiber or a mixed fiber of the above fibers; S5: coating the surface of the polymer fiber treated by plasma in step S4 with a silk protein solution; the method for coating the surface of the polymer fiber treated by plasma in step S4 with a silk protein solution in step S5 is: adding growth factors to the silk protein solution, stirring to dissolve, and immersing the polymer fiber treated by plasma in step S4 in the silk protein solution added with growth factors; S6: twisting the regenerated silk protein fiber containing growth factors obtained in step S3 and the surface-modified polymer fiber obtained in step S5 into fibers in an appropriate ratio to prepare hybrid fibers; The growth factor is selected from magnesium ion compounds, calcium ions, FGF21 or nano zinc.
2. The method for preparing hybrid fiber according to claim 1, characterized in that: In step S6, the ratio of the regenerated silk protein fibers containing growth factors to the surface-modified polymer fibers is 1:99 to 99:
1.
3. The method for preparing hybrid fiber according to claim 1, characterized in that: In step S6, the ratio of the regenerated silk fiber containing growth factors to the surface-modified polymer fiber is 1:50 to 50:
1.
4. The method for preparing hybrid fiber according to claim 1, characterized in that: In the step S6, the ratio of the regenerated silk protein fibers containing growth factors to the surface-modified polymer fibers is 1:20 to 20:
1.
5. The method for preparing hybrid fiber according to claim 1, characterized in that: In the step S6, the ratio of the regenerated silk protein fibers containing growth factors to the surface-modified polymer fibers is 1:4 to 4:
1.
6. The method for preparing hybrid fiber according to any one of claims 1 to 5, characterized in that: The method for preparing high-concentration regenerated silk protein stock solution in step S1 is as follows: a) degumming: putting mulberry silk into an aqueous solution of sodium carbonate, sodium bicarbonate or a mixed solution of sodium carbonate and sodium bicarbonate, heating and boiling, taking out and washing with purified water, removing sericin, leaving silk protein, drying the silk protein, obtaining dried silk protein for standby use; b) dissolving: dissolving the dried silk protein in an aqueous solution of lithium bromide to obtain a mixed solution containing silk protein and a small amount of insoluble particles; c) filtering: filtering the mixed solution for multiple times to obtain a clarified lithium bromide protein solution; d) ultrafiltration: taking the clarified solution, adding purified water to dilute it, passing it into an ultrafiltration system for desalination, and concentrating the silk protein concentration of the final solution to 5-40wt%.
7. A hybrid fiber capable of promoting tissue regeneration, characterized in that: Prepared by the method according to any one of claims 1 to 6.
8. A fiber structure, characterized in that By subjecting the hybrid fiber prepared by the method of any one of claims 1 to 6 to corresponding process treatment, a structure suitable for different usage scenarios is obtained, including an artificial ligament, an artificial hernia patch or an artificial tendon.
